UNSPSC 51162705: Brovanexine

This classification denotes a mucolytic agent with the molecular formula C24H28Br2N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) Y00SD533IW, chemically known as 4-acetoxy-2,4-dibrom-6-((n-cyclohexylmethylamino)methyl)-3-methoxybenzanilid but more generally known as brovanexine, which bears US NIH Compound Identifier 162137. Brovanexine most often comes in base and hydrochloride forms.

UNSPSC 51162705 Brovanexine is a Commodity code that covers pharmaceutical products supplied to state and local health and correctional facilities. Recent solicitations show state and local governments purchasing parenteral nutrition solutions, intravenous products, naloxone, and related pharmaceutical items for delivery to correctional institutions and public health departments. The Washington State Department of Corrections is a primary active buyer under this code, soliciting parenteral products, services, and equipment including total parenteral nutrition (TPN), peripheral parenteral nutrition (PPN), intravenous solutions, and controlled substances for healthcare delivery to incarcerated individuals across eight correctional facilities. Issuing bodies include state corrections departments and county health departments; the code shows activity from both security and public-health procurement functions, with an emphasis on pharmaceutical supply contracts that carry strict delivery timelines, insurance requirements, and compliance obligations around controlled-substance handling and patient safety.

Recent activity appears concentrated in Washington State and Florida. The Washington State Department of Corrections issued RFQQ 13020 on September 8, 2026, for parenteral products and services across West, Central, and East regional facilities, with a response deadline of October 7, 2026 at 4:00 PM PST and a pre-bid conference on September 23, 2026; the contract encourages small business (25%), minority-owned business (10%), women-owned business (6%), and veteran-owned business (5%) participation and anticipates awarding up to three contractors per region through June 30, 2030. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to the Seminole County Community Health Building, with a response deadline of July 26, 2023 at 2:00 PM. Contractors must meet Washington State business licensing, background clearance, and insurance requirements including commercial general liability, professional liability, business automobile liability, and cyber liability; delivery performance is critical, with some pharmaceutical products required within 8 to 24 hours of order.